Get the Stockscreener App
9.04
0.11%
-0.04
Cervomed Inc Stock (CRVO) Forecast
The Cervomed Inc (CRVO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $111.01, representing a +1,128% increase from the current price of $9.04. The highest analyst price target is $120.42, and the lowest is $101.60.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CRVO Price Target
Average 183.33
(+1,928% Upside)
Is Cervomed Inc (CRVO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 56.94 | Neutral |
| STOCH(9,6) | 51.16 | Neutral |
| STOCHRSI(14) | 30.07 | Neutral |
| MACD(12,26) | 0.3621 | Sell |
| ADX(14) | 19.43 | Neutral |
| William %R | -40.36 | Neutral |
| CCI(14) | 9.7149 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
9.137
Sell
|
8.8647
Buy
|
| MA20 |
8.4315
Buy
|
8.5741
Buy
|
| MA50 |
7.9843
Buy
|
8.2706
Buy
|
| MA100 |
8.5154
Buy
|
8.2139
Buy
|
| MA200 |
8.0356
Buy
|
8.4594
Buy
|
Buy: 9
Sell: 1
Neutral: 0
Summary: Buy
According to our latest analysis, CRVO could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 2 signaling Sell signals and 6 Neutral signals. This might be a good time to open fresh positions on CRVO, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 56.94 indicates that CRVO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 51.16 indicates that CRVO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 30.07 indicates that CRVO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 19.43 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 9.7149 indicates that CRVO is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term CRVO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cervomed Inc financial reports and earnings history, Cervomed Inc (CRVO) stock could reach $426.16 by 2030, $1,140.10 by 2040 and $1,956.81 by 2050. See the projected annual prices until 2050 of the Cervomed Inc stock below:
- Cervomed Inc (CRVO) is expected to reach an average price of $290.03 in 2035, with a high prediction of $1,241.14 and a low estimate of $289.95. This indicates an $3,108% rise from the last recorded price of $9.04.
- Cervomed Inc (CRVO) stock is projected to chart a bullish course in 2040, with an average price target of $1,138.56, representing an $12,495% surge from its current level. The forecast ranges from a conservative $1,026.83 to a sky-high $1,140.10.
- Our analysts predict Cervomed Inc (CRVO) to jump 6,380% by 2045, soaring from $536.82 to an average price of $585.78, potentially reaching $2,370.42. While $536.82 is the low estimate, the potential upside is significant.
- Cervomed Inc (CRVO) stock is expected to climb by 2050, reaching an average of $1,956.75, a $21,545% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1,956.81 and $1,777.01, respectively, highlighting the market's uncertainty.
Cervomed Inc Stock (CRVO) Year by Year Forecast
Cervomed Inc Stock (CRVO) Price Forecast for 2026
The predicted value for Cervomed Inc (CRVO) in 2026 is set at an average of $183.33. Estimates vary from a peak of $285.60 to a trough of $81.06, indicating an +1,928% surge from the present price of $9.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $119.03 | $101.60 | $120.42 | +1,217% |
| February, 2026 | $140.07 | $123.73 | $140.12 | +1,449% |
| March, 2026 | $158.58 | $143.78 | $158.58 | +1,654% |
| April, 2026 | $185.40 | $163.20 | $186.33 | +1,951% |
| May, 2026 | $211.65 | $190.35 | $214.95 | +2,241% |
| June, 2026 | $236.83 | $215.43 | $237.06 | +2,520% |
| July, 2026 | $268.94 | $242.06 | $270.86 | +2,875% |
| August, 2026 | $81.14 | $81.06 | $285.60 | +797.57% |
| September, 2026 | $118.26 | $87.82 | $118.29 | +1,208% |
| October, 2026 | $149.55 | $125.22 | $149.55 | +1,554% |
| November, 2026 | $176.26 | $154.78 | $176.81 | +1,850% |
| December, 2026 | $208.90 | $183.17 | $208.90 | +2,211% |
Cervomed Inc Stock (CRVO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cervomed Inc (CRVO) is $236.78, with a high forecast of $373.52 and a low forecast of $100.05. This indicates an +2,519% increase from the last price of $9.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $238.36 | $215.25 | $238.42 | +2,537% |
| February, 2027 | $273.75 | $244.36 | $275.47 | +2,928% |
| March, 2027 | $309.78 | $277.00 | $310.01 | +3,327% |
| April, 2027 | $344.81 | $316.74 | $345.41 | +3,714% |
| May, 2027 | $360.53 | $348.58 | $372.47 | +3,888% |
| June, 2027 | $136.17 | $100.05 | $136.17 | +1,406% |
| July, 2027 | $173.22 | $144.93 | $173.76 | +1,816% |
| August, 2027 | $209.69 | $181.47 | $209.88 | +2,220% |
| September, 2027 | $249.63 | $217.86 | $251.40 | +2,661% |
| October, 2027 | $287.00 | $257.44 | $287.00 | +3,075% |
| November, 2027 | $323.50 | $295.22 | $324.01 | +3,478% |
| December, 2027 | $372.65 | $332.69 | $373.52 | +4,022% |
Cervomed Inc Stock (CRVO) Price Forecast for 2028
In 2028, Cervomed Inc (CRVO) is projected to reach an average price of $332.62, with a high projection of $546.20 and a low estimate of $119.04. This indicates an +3,579% rise from the last price of $9.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $411.33 | $380.66 | $415.03 | +4,450% |
| February, 2028 | $449.92 | $420.41 | $450.63 | +4,877% |
| March, 2028 | $149.89 | $119.04 | $459.34 | +1,558% |
| April, 2028 | $195.52 | $160.32 | $198.82 | +2,063% |
| May, 2028 | $249.56 | $205.91 | $249.75 | +2,661% |
| June, 2028 | $289.53 | $259.47 | $290.46 | +3,103% |
| July, 2028 | $331.58 | $298.17 | $333.11 | +3,568% |
| August, 2028 | $386.00 | $342.06 | $386.51 | +4,170% |
| September, 2028 | $429.70 | $396.93 | $430.39 | +4,653% |
| October, 2028 | $481.85 | $439.12 | $482.55 | +5,230% |
| November, 2028 | $535.05 | $488.96 | $535.76 | +5,819% |
| December, 2028 | $161.64 | $138.03 | $546.20 | +1,688% |
Cervomed Inc Stock (CRVO) Price Forecast for 2029
The 2029 price forecast for Cervomed Inc Stock (CRVO) is $395.05 on average, with a high prediction of $633.07 and a low estimate of $157.02. This represents an +4,270% increase from the previous price of $9.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $226.69 | $173.76 | $229.99 | +2,408% |
| February, 2029 | $276.81 | $238.82 | $277.59 | +2,962% |
| March, 2029 | $324.93 | $288.86 | $325.48 | +3,494% |
| April, 2029 | $373.81 | $336.37 | $374.10 | +4,035% |
| May, 2029 | $433.48 | $385.38 | $434.06 | +4,695% |
| June, 2029 | $487.79 | $445.85 | $488.44 | +5,296% |
| July, 2029 | $544.69 | $499.10 | $549.17 | +5,925% |
| August, 2029 | $607.53 | $551.17 | $609.21 | +6,620% |
| September, 2029 | $171.17 | $157.02 | $633.07 | +1,794% |
| October, 2029 | $246.67 | $184.11 | $248.24 | +2,629% |
| November, 2029 | $301.01 | $257.46 | $302.40 | +3,230% |
| December, 2029 | $356.85 | $314.40 | $356.90 | +3,847% |
Cervomed Inc Stock (CRVO) Price Forecast for 2030
Cervomed Inc Stock (CRVO) is expected to reach an average price of $447.97 in 2030, with a high forecast of $719.94 and a low forecast of $176.01. This signifies an +4,855% surge from the last price of $9.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $425.87 | $369.26 | $426.16 | +4,611% |
| February, 2030 | $480.50 | $439.18 | $481.43 | +5,215% |
| March, 2030 | $541.56 | $494.15 | $544.86 | +5,891% |
| April, 2030 | $601.55 | $554.04 | $601.78 | +6,554% |
| May, 2030 | $677.17 | $615.48 | $679.09 | +7,391% |
| June, 2030 | $176.09 | $176.01 | $719.94 | +1,848% |
| July, 2030 | $256.72 | $191.47 | $256.75 | +2,740% |
| August, 2030 | $322.82 | $272.38 | $322.82 | +3,471% |
| September, 2030 | $384.34 | $336.75 | $384.89 | +4,152% |
| October, 2030 | $460.49 | $399.96 | $460.49 | +4,994% |
| November, 2030 | $524.76 | $475.55 | $524.82 | +5,705% |
| December, 2030 | $594.95 | $539.46 | $596.67 | +6,481% |
0.04%
1.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):